ALD n°13 - Maladie coronarienne - ALD n° 13 - Guide for doctors - long-term conditions : Coronary artery disease

Has

Description

Posted on May 21 2007 The aim of this guide for medical practitioners is to describe the best form of management and the care pathway for a patient entering the ALD [Long-term condition] scheme with ALD 13: coronary artery disease. The aim of this guide for medical practitioners is to describe the best form of management and the care pathway for a patient entering the ALD [Long-term condition] scheme with ALD 13: coronary artery disease. Posted on May 21 2007

Sujets

• Cardiopathie coronarienne
• Cardiopathie
• Médecine

Informations

• Publié par: haute-autorite-sante-maladies-cardiaques
• Publié le: 01 mars 2007
• Nombre de lectures: 27
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

 

                 

                 

GUIDE FOR DOCTORS : LONG-TERM CONDITIONS

CORONARY ARTERY DISEASE

MARCH 2007

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This document may be downloaded from www.has-sante.fr

  Haute Autorité de Santé Communications Department 2 avenue du Stade de France - F 93218 Saint-Denis La Plaine CEDEX Tel.: [phone] - Fax: [phone]  

  This document was validated by HAS Board in March 2007. © Haute Autorité de Santé – 2007

2

Contents 

 

Abbreviations..................................................................................................5  

Introduction.....................................................................................................6  

Coronary artery disease.................................................................................8  

1  

2  

3  

Initial evaluation....................................................................................8  

Therapeutic management .................................................................... 13  

Follow-up of patients with chronic ischemic heart disease............. 16  

Control of CV-RF.............................................................................................18  

4  

5  

6  

Baseline assessment...........................................................................18  

Clinical management of cardiovascular risk.....................................19  

Follow-up...............................................................................................23  

Appendix 1. List of persons who helped draft this guide........................... 25  

Appendix 2. Classification of the Canadian Cardiology Society ............... 26  

Appendix 3. Fagerström test.........................................................................27  

Appendix 4. References.................................................................................28    

3